COVID-19-associated blood plasma inflammatory factors do not affect blood-brain barrier, study shows

It is now well documented that the coronavirus outbreak triggered a global health crisis. In this study, researchers wanted to know whether blood-brain barrier impairment contributed to the development of neurological problems during COVID-19 progression, and to what extent.

FDA posts updated safety data on Bayer’s Essure, notes progress on improving study

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: A postmarket surveillance study has

October 31, 2023

Almirall to license Eloxx’s ZKN-013 for rare skin conditions

Share this article Almirall will develop and market the drug candidate for rare dermatological ailments. Credit: JPC-PROD / Shutterstock.com. Almirall has signed an exclusive licence

March 14, 2024

GPT-4 matches radiologist accuracy in spotting errors, cuts time and costs dramatically

Researchers found that GPT-4 effectively identified and corrected errors in radiology reports, demonstrating comparable accuracy to human radiologists but with increased time efficiency and cost-effectiveness.

April 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.